Next Article in Journal
Expression of Organic Anion Transporter Polypeptides (OATPs) in Human Breast Carcinoma
Previous Article in Journal
Reverse Chemical Proteomics in Drug Discovery
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats

1
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
2
Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
3
Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Karl-Franzens-University Graz, 8010 Graz, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 195; https://doi.org/10.3797/scipharm.oephg.21.SL-28
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

This study assessed the absolute and relative bioavailabilities of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (tetraene), one of the main bioactive constituents in Echinacea, administered as pure compounds or as an Echinacea purpurea root extract preparation. Ten rats received 0.75 mg/kg dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides oral, pure and within 158.6 mg/kg Echinacea purpurea extract, or intravenous.[...]

Share and Cite

MDPI and ACS Style

WÖLKART, K.; FRYE, R.; DERENDORF, H.; BAUER, R.; BUTTERWECK, V. Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Sci. Pharm. 2009, 77, 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28

AMA Style

WÖLKART K, FRYE R, DERENDORF H, BAUER R, BUTTERWECK V. Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):195. https://doi.org/10.3797/scipharm.oephg.21.SL-28

Chicago/Turabian Style

WÖLKART, K., R. FRYE, H. DERENDORF, R. BAUER, and V. BUTTERWECK. 2009. "Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats" Scientia Pharmaceutica 77, Short Lectures (SL): 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28

APA Style

WÖLKART, K., FRYE, R., DERENDORF, H., BAUER, R., & BUTTERWECK, V. (2009). Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Scientia Pharmaceutica, 77(Short Lectures (SL)), 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28

Article Metrics

Back to TopTop